ArticleBreast cancer research and treatment2024

The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study.

Murad Guliyev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.